Haemophilus B Conjugate Vaccine - Drug Information
Generic Name : Haemophilus B Conjugate Vaccine
Pronunciation : hem-OFF-fil-us pol-i-SAK-ka-ride
ICD Code : Y58.9 | Therapeutic Classification : Immunizing Agents
Trade Name(s) :
International - ActHIB and PedvaxHIB.
Why is Haemophilus B Conjugate Vaccine Prescribed? (Indications)
This medication is an immunization agent, prescribed as an active immunization of infants and children for Haemophilus influenza type B bacteria and/or diphtheria, tetanus, and pertussis infections.
When should Haemophilus B Conjugate Vaccine not to be taken? (Contraindications)
Hypersensitivity.What is the dosage of Haemophilus B Conjugate Vaccine ?
A single intramuscular injection (approximately 0.5 mL) after reconstitution.
How should Haemophilus B Conjugate Vaccine be taken?
It comes as a solution for injection to be administered by a healthcare provider into the large muscle.
What are the warnings and precautions for Haemophilus B Conjugate Vaccine ?
* Caution should be exercised in patients with history of bleeding disorder, any allergy, who are taking other medications, during pregnancy and breastfeeding.* It should not be used in infants younger than 2 months.
* Before using this medication it is necessary to consult with healthcare provider about previous vaccination series.
* Additional monitoring needed for children who are taking immunosuppressive therapy.